Highlights in Resistance Mechanism Pathways for Combination Therapy

Area of Science:

• Oncology
• Pharmacology
• Molecular Biology

Background:

• Combination chemotherapy is a cornerstone of cancer treatment, yet its underlying mechanisms are often poorly understood.
• While single anticancer agents' pathways are known, most drug combinations lack clear mechanistic insights.
• Resistance to chemotherapy remains a significant challenge in cancer therapy.

Purpose of the Study:

• To review common signaling pathway alterations in response to cytotoxic and targeted anticancer drugs.
• To discuss how understanding signaling pathways can inform innovative combination therapy strategies.
• To highlight potential combination therapies based on resistance-associated signaling pathways to improve cancer cell death.

Main Methods:

• Literature review of signaling pathways affected by anticancer drugs.
• Analysis of resistance mechanisms in cancer cells.
• Compilation of updated information on chemotherapy resistance.

Main Results:

• Identified common signaling pathway alterations induced by various anticancer treatments.
• Detailed mechanisms of chemoresistance linked to specific signaling pathways.
• Provided a framework for developing rational drug combinations.

Conclusions:

• Knowledge of signaling pathways is crucial for designing effective anticancer combination therapies.
• Targeting resistance mechanisms through pathway-informed combinations can enhance treatment efficacy.
• This review compiles essential information to foster the development and testing of new combination strategies.